- Latest available (Revised)
- Original (As made)
There are outstanding changes not yet made by the legislation.gov.uk editorial team to The Medicines (Products for Human Use) (Fees) Regulations 2016. Any changes that have already been made by the team appear in the content and are referenced with annotations.
Revised legislation carried on this site may not be fully up to date. Changes and effects are recorded by our editorial team in lists which can be found in the ‘Changes to Legislation’ area. Where those effects have yet to be applied to the text of the legislation by the editorial team they are also listed alongside the legislation in the affected provisions. Use the ‘more’ link to open the changes and effects relevant to the provision you are viewing.
Whole provisions yet to be inserted into this Instrument (including any effects on those provisions):
Regulations 30(1); 34;35(2) and (3); and 36(1)
1.—(1) In this Schedule, a reference to 1 day means a period of 7 hours.
(2) For the purposes of paragraphs 3(2)(c), 4(2)(c), 6(2)(c) and 8, in calculating the number of days taken to make an inspection, any part day shall be calculated as a whole day.
(3) Where an inspection is made at a site which is outside the United Kingdom, the fee for the inspection shall be increased by an amount equal to the travelling and subsistence costs of the inspector relating to the inspection and any additional costs (such as interpreters' fees) reasonably incurred by the inspector in respect of that inspection as a result of its being at a site outside the United Kingdom.
(4) If an inspection is made by more than one inspector, the time taken by the licensing authority to make an inspection is the total amount of time spent by each inspector in making the inspection.
2.—(1) The fee for an inspection made at a site is—
(a)£2,655, if the time taken to make the inspection is not more than 1 day; and
(b)thereafter, £1,328 for every additional period of 3 hours and 30 minutes or less taken to make the inspection.
(2) Sub-paragraph (1) does not apply if the inspection is one for which a fee is payable under paragraphs 3 to 7.
3.—(1) Sub–paragraph (2) applies if the site inspected is wholly concerned with the manufacture, assembly or import from a third country of traditional herbal medicinal products.
(2) If this sub-paragraph applies, the fee payable in respect of an inspection of a site in connection with the grant, variation or renewal of a manufacturer's licence or during the currency of such a licence, is—
(a)£994 if the time taken to make the inspection is not more than 3 hours;
(b)£1,615 if the time taken to make the inspection is more than 3 hours but not more than 1 day; and
(c)if the time taken to make the inspection is more than 1 day, the amount calculated by multiplying the total number of days taken to make the inspection by £1,615.
4.—(1) Sub-paragraph (2) applies if the site inspected is wholly concerned with the manufacture or assembly of starting material for use in the manufacture of traditional herbal medicinal products.
(2) If this sub-paragraph applies, the fee payable in respect of an inspection of an API manufacturer under Article 111(1g)(a) of the 2001 Directive, is—
(a)£994 if the time taken to make the inspection is not more than 3 hours;
(b)£1,615 if the time taken to make the inspection is more than 3 hours but not more than 1 day; and
(c)if the time taken to make the inspection is more than 1 day, the amount calculated by multiplying the total number of days to make the inspection by £1,615.
5. Except in the case of an inspection falling within paragraphs 6 or 7, the fee for an inspection of a site made in connection with the grant or variation of a wholesale dealer's licence or during the currency of such a licence, is—
(a)if the time taken to make the inspection is not more than 1 day, £1,936; and
(b)if the time taken is 1 day or more, £1,936 for the first day and £968 for every subsequent period of 3 hours and 30 minutes or less taken to make the inspection.
6.—(1) Sub–paragraph (2) applies if the site inspected is wholly concerned with the wholesale dealing of traditional herbal medicinal products.
(2) If this sub-paragraph applies, the fee payable in respect of an inspection of a site in connection with the grant, variation or renewal of a wholesale dealer's licence or during the currency of such a licence is—
(a)£744 if the time taken to make the inspection is not more than 3 hours;
(b)£1,367 if the time taken to make the inspection is more than 3 hours but not more than 1 day; and
(c)if the time taken to make the inspection is more than 1 day, the amount calculated by multiplying the total number of days taken to make the inspection by £1,367.
7.—(1) Sub-paragraph (3) applies if the time taken to make the inspection is not more than 3 hours and 30 minutes, and
(a)the site is that of a wholesale dealer whose licence is limited to dealing only in medicinal products classified as subject to general sale under regulation 5(1) of the Human Medicines Regulations;
(b)the site relates to a registered pharmacy as referred to in paragraph 31(3) of Part 2 of Schedule 2; or
(c)the total turnover in respect of sales by way of wholesale dealing in authorised medicinal products of the wholesale dealer does not exceed £35,000.
(2) If paragraph (c) of sub-paragraph (1) applies because the applicant has not held a wholesale dealer's licence during the 12 month period preceding the date of the application, sub–paragraph (1) does not apply unless at the time of making the application—
(a)it is reasonable for the applicant to believe that the gross amount of total sales of authorised medicinal products likely to be made in the period of 12 months following the grant of the licence will not exceed £35,000; and
(b)the applicant so informs the licensing authority.
(3) If this sub-paragraph applies, the fee payable in respect of an inspection of a site made in connection with the grant, variation or renewal of a wholesale dealer's licence is £968.
8.—(1) Except in the case of an inspection where sub–paragraph (2) applies, the inspection fee payable in connection with the grant, variation or review of a broker's registration is—
(a)£1,936 if the time taken to make the inspection is not more than 1 day; and
(b)if the time taken is 1 day or more, £1,936 for the first day and £968 for every subsequent period of 3 hours and 30 minutes or less taken to make the inspection.
(2) This paragraph applies where an application or variation of a broker's registration is considered under paragraph 10 but it is necessary to carry out a site inspection before the registration is granted or varied.
(3) If sub-paragraph (2) applies, a fee of £582 is payable in addition to any fee under paragraph 10.
9.—(1) Except in the case of an inspection where sub–paragraph (2) applies, the fee payable in connection with the grant, variation or review of an active substance registration where the inspection relates to—
(a)a manufacturer of an active substance, is—
(i)£2,655 if the time taken to make the inspection is not more than 1 day; and
(ii)if the time taken is 1 day or more, £2,655 for the first day and £1,328 for every subsequent period of 3 hours and 30 minutes or less taken to make the inspection;
(b)an importer or distributor of an active substance, is—
(i)£1,936 if the time taken to make the inspection is not more than 1 day; and
(ii)if the time taken is 1 day or more, £1,936 for the first day and £968 for every subsequent period of 3 hours and 30 minutes or less taken to make the inspection.
(2) This paragraph applies where an application or variation of an active substance registration is considered under paragraph 10 but it is necessary to carry out a site inspection before the registration is granted or varied.
(3) If sub-paragraph (2) applies—
(a)a fee of £792 is payable in addition to any fee under paragraph 10 where the inspection relates to a manufacturer of an active substance;
(b)a fee of £582 is payable in addition to any fee under paragraph 10 where the inspection relates to an importer or distributor of an active substance.
10. The fee for an inspection comprising an office-based evaluation and risk assessment of documentation but not involving inspection of a site, in connection with the monitoring of—
(a)good manufacturing practice, good clinical practice or good pharmacovigilance practice, is £1,863 per day;
(b)good distribution practice, is £1,354 per day.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: